ArticleNPJ primary care respiratory medicine2022

Improvement in symptom-related disruptions is associated with fewer days of short-acting beta-agonist use in asthma.

Leanne Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.